Allergan Ligand, Ligand preclinical data

LGND researchers and colleagues published the ability of the company's RXR agonists to function as insulin sensitizers and to reverse the signs of diabetes in mouse

Read the full 264 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE